| abstract |
The compounds of formula (I) and the compounds of formula (II) below and their pharmaceutically acceptable salts are described. Compounds of formulas (I) and (II) below are antagonists of NMDA receptor channel complexes useful for treating cerebrovascular disorders such as cerebral ischemia, cardiac arrest, stroke and Parkinson's disease.n n n <Formula I>n n n n n n n n <Formula II> |